Skip to main content
Equibles

Andrew Guggenhime

CFO

Vaxcyte, Inc. (PCVX)

Board Member

Caribou Biosciences, Inc. (CRBU)
Vaxcyte, Inc. (PCVX)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Andrew Guggenhime

Andrew Guggenhime is recorded as CFO at Vaxcyte, Inc. (PCVX) and Board Member at Caribou Biosciences, Inc. (CRBU). The proxy statement of Vaxcyte, Inc. reports total compensation of $6,072,939 for Andrew Guggenhime in fiscal 2025, including a base salary of $620,000. Disclosed compensation is on record for 6 fiscal years. Andrew Guggenhime has spoken on 6 earnings calls and 1 other investor event across 1 company, most recently for Vaxcyte, Inc. on September 8, 2026.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Vaxcyte, Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at Caribou Biosciences, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Vaxcyte, Inc. (PCVX) $620,000 $6,072,939
2024 Vaxcyte, Inc. (PCVX) $556,000 $17,878,117
2023 Vaxcyte, Inc. (PCVX) $517,000 $5,415,277
2022 Vaxcyte, Inc. (PCVX) $493,658 $6,902,093
2021 Vaxcyte, Inc. (PCVX) $472,400 $2,753,001
2020 Vaxcyte, Inc. (PCVX) $274,792 $5,650,072

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.